Historical Valuation
Adaptive Biotechnologies Corp (ADPT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 9.57 is considered Undervalued compared with the five-year average of -11.20. The fair price of Adaptive Biotechnologies Corp (ADPT) is between 88.39 to 93.21 according to relative valuation methord. Compared to the current price of 15.76 USD , Adaptive Biotechnologies Corp is Undervalued By 82.17%.
Relative Value
Fair Zone
88.39-93.21
Current Price：15.76
82.17%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Adaptive Biotechnologies Corp (ADPT) has a current Price-to-Book (P/B) ratio of 11.87. Compared to its 3-year average P/B ratio of 4.52 , the current P/B ratio is approximately 162.58% higher. Relative to its 5-year average P/B ratio of 4.80, the current P/B ratio is about 147.49% higher. Adaptive Biotechnologies Corp (ADPT) has a Forward Free Cash Flow (FCF) yield of approximately -2.59%. Compared to its 3-year average FCF yield of -16.62%, the current FCF yield is approximately -84.41% lower. Relative to its 5-year average FCF yield of -14.44% , the current FCF yield is about -82.05% lower.
P/B
Median3y
4.52
Median5y
4.80
FCF Yield
Median3y
-16.62
Median5y
-14.44
Competitors Valuation Multiple
AI Analysis for ADPT
The average P/S ratio for ADPT competitors is 214.14, providing a benchmark for relative valuation. Adaptive Biotechnologies Corp Corp (ADPT.O) exhibits a P/S ratio of 9.57, which is -95.53% above the industry average. Given its robust revenue growth of 102.38%, this premium appears sustainable.
Performance Decomposition
AI Analysis for ADPT
1Y
3Y
5Y
Market capitalization of ADPT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ADPT in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ADPT currently overvalued or undervalued?
Adaptive Biotechnologies Corp (ADPT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 9.57 is considered Undervalued compared with the five-year average of -11.20. The fair price of Adaptive Biotechnologies Corp (ADPT) is between 88.39 to 93.21 according to relative valuation methord. Compared to the current price of 15.76 USD , Adaptive Biotechnologies Corp is Undervalued By 82.17% .
What is Adaptive Biotechnologies Corp (ADPT) fair value?
ADPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Adaptive Biotechnologies Corp (ADPT) is between 88.39 to 93.21 according to relative valuation methord.
How does ADPT's valuation metrics compare to the industry average?
The average P/S ratio for ADPT's competitors is 214.14, providing a benchmark for relative valuation. Adaptive Biotechnologies Corp Corp (ADPT) exhibits a P/S ratio of 9.57, which is -95.53% above the industry average. Given its robust revenue growth of 102.38%, this premium appears sustainable.
What is the current P/B ratio for Adaptive Biotechnologies Corp (ADPT) as of Jan 10 2026?
As of Jan 10 2026, Adaptive Biotechnologies Corp (ADPT) has a P/B ratio of 11.87. This indicates that the market values ADPT at 11.87 times its book value.
What is the current FCF Yield for Adaptive Biotechnologies Corp (ADPT) as of Jan 10 2026?
As of Jan 10 2026, Adaptive Biotechnologies Corp (ADPT) has a FCF Yield of -2.59%. This means that for every dollar of Adaptive Biotechnologies Corp’s market capitalization, the company generates -2.59 cents in free cash flow.
What is the current Forward P/E ratio for Adaptive Biotechnologies Corp (ADPT) as of Jan 10 2026?
As of Jan 10 2026, Adaptive Biotechnologies Corp (ADPT) has a Forward P/E ratio of -25.25. This means the market is willing to pay $-25.25 for every dollar of Adaptive Biotechnologies Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Adaptive Biotechnologies Corp (ADPT) as of Jan 10 2026?
As of Jan 10 2026, Adaptive Biotechnologies Corp (ADPT) has a Forward P/S ratio of 9.57. This means the market is valuing ADPT at $9.57 for every dollar of expected revenue over the next 12 months.